Archive - February 2018
Lilly’s Taltz hits goals in PhIII ankylosing spondylitis trial
Bicycle, CR UK launch first trial of a bicyclic peptide
Novartis gets $6.5m from Gates Foundation for diarrhoea drug
MSD’s verubecestat fails again in Alzheimer’s trial
MSD shuts down Phase 3 trial in prodromal Alzheimer’s
Pfizer taps real world evidence for CVD in new partnership
Bill & Melinda Gates Foundation shows faith in CureVac
Food Allergies: To Test or Not to Test